Wearable devices are increasingly popular tools for tracking health and enhancing athletic perfromance performance. However, solutions often have shortcomings. “Many currently available devices are inaccurate, have limited features and are relatively intrusive to wear,” says Hubertus Hoyt, former Vice President and General Manager of Nike Western Europe and EMEA, who recently joined dBio as Board Advisor.
To address these limitations, dBio is developing next-generation wearable solutions powered by AIoT (artificial intelligence of things) to provide athletic performance monitoring with real-time health insights. Its flagship product, the gMOT Cloud, is a smart insole sensor system designed to deliver real-time insights on performance metrics including power, speed, acceleration, heart rate and blood oxygen levels. With its discreet, lightweight design, the device offers precision tracking without compromising user comfort.
The company’s innovations also include an AI-powered wearable stethoscope. Weighing just 15 grams, it continuously monitors heart activity, alerts users to irregularities and supports applications in telemedicine and palliative care.
A shared vision for healthtech innovation
dBio’s solutions are fully developed in-house and protected by over 75 registered patents. The company is gearing up for mass production and market expansion. Luxembourg, known for its strong healthtech ecosystem, has proven to be an ideal partner.
“Luxembourg is renowned for healthtech innovation and for helping companies like dBio get started in Europe,” says Mr Hoyt.
“The direction where Europe – and especially Luxembourg – is heading aligns perfectly with our vision,” continues Edward Chou, Executive Assistant to the Chairman of dBio. “The government is dedicated and committed to digital health, which is very interesting for us.”
Luxembourg is renowned for healthtech innovation and for helping companies like dBio get started in Europe.
The decision to set up in Luxembourg followed a visit organised with support from the Luxembourg Trade and Investment Office (LTIO) in Taipei. “We found a thriving ecosystem of incubators, venture capital and potential partners,” says Mr Chou. “The talent pool here is exceptional—multilingual and highly skilled—which is exactly what we need as we grow.”
Forging new research partnerships
Research and development remain at the heart of dBio’s operations. Its new AI research centre in Luxembourg will tailor solutions for the European market, with a particular focus on sports such as golf and cycling.
In addition to collaborations with several medical institutions in Taiwan, dBio has partnered with LUNEX University of Applied Science, a local institution specialising in physiotherapy, sports science and sport management. The company is also exploring further partnerships within the region.
Business done efficiently
Mr Chou is impressed by Luxembourg’s business environment. “In our experience, efficiency is the word that describes everything here. Everyone is very professional and knows exactly where they are going. This is something that we appreciate.”
We found a thriving ecosystem of incubators, venture capital and potential partners.
He also praises the support provided by LTIO Taipei and Luxinnovation, the national innovation agency. “Having a trusted agency to point you in the right direction when you are new to a country is the biggest support anyone can ask for. We are very grateful for that.”
Photo credits: dBio